AWE
SYRS

Avidian Wealth Enterprises’s Syros Pharmaceuticals, Inc. Common Stock SYRS Stock Holding History

Avidian Wealth Enterprises’s Portfolio SYRS Stock Details SYRS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-1,600
Closed -$120K – 407
2021
Q1 		$120K Buy
+1,600
New +$120K 0.01% 352